MCRB Seres Therapeutics Inc

USD 0.83 0.00 0
Icon

Seres Therapeutics Inc (MCRB) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Under-perform

Average Analyst
Rating
stockTargetAdvisor

Under-perform

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.825

0.00 (0.00)%

USD 0.12B

3.98M

USD 2.45(+196.97%)

N/A

Icon

MCRB

Seres Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 0.83
0.00 0
Take a Tour

Seres Therapeutics Inc (MCRB) Stock Forecast

Show ratings and price targets of :
USD 2.45
(+196.97%)

Based on the Seres Therapeutics Inc stock forecast from 2 analysts, the average analyst target price for Seres Therapeutics Inc is USD 2.45 over the next 12 months. Seres Therapeutics Inc’s average analyst rating is Under-perform. Stock Target Advisor’s own stock analysis of Seres Therapeutics Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Seres Therapeutics Inc’s stock price was USD 0.825. Seres Therapeutics Inc’s stock price has changed by +47.35% over the past week, +5.74% over the past month and -83.08% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...